Hansen Medical(R) Announces Exclusive Distribution Agreement for Switzerland With AB Medica Sagl

MOUNTAIN VIEW, CA--(Marketwired - Oct 1, 2015) - Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced that it has signed an exclusive agreement with AB Medica Sagl for distribution of the Magellan™ Robotic System in Switzerland. AB Medica, s.p.a. is the company's exclusive distributor for Italy. As part of the agreement, Hansen Medical sold and shipped a Magellan system to AB Medica on September 30, 2015.

"We are pleased to expand our relationship with AB Medica to include exclusive distribution of the Magellan Robotic System in Switzerland," said Cary Vance, President and CEO of Hansen Medical. "This is another important step in the development of a strong global market for intravascular robotic systems. AB Medica is the largest medical technology distributor in Italy and Switzerland, and this expanded partnership will enable more patients to access and benefit from robotic endovascular procedures with Magellan."

The Magellan Robotic System is an advanced technology that drives Magellan Robotic Catheters and guide wires during minimally-invasive, endovascular procedures. Magellan is designed to offer procedural predictability, precision, and catheter stability as physicians navigate inside blood vessels and deliver therapy. Image-guided medical procedures using interventional fluoroscopy, while growing rapidly, are the leading source of occupational ionizing radiation exposure for medical personnel¹. Magellan's remote workstation allows physicians to control robotic catheters and guide wires while seated away from the radiation field, which has been shown to reduce radiation exposure for the physician by as much as 95% in complex endovascular procedures².

About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan Robotic System is designed to deliver predictability, control and catheter stability to endovascular procedures. Since its commercial introduction in the U.S. and Europe, the Magellan Robotic System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedures globally. The Magellan Robotic System offers several important features including: